Nurix Therapeutics Inc.
NRIX | NASDAQ
$25.55
+$0.14 (+0.55%)
Sep 22, 2026, 10:35 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 May 30, 2026 | Q1 2026 Feb 27, 2026 | Q4 2025 Nov 29, 2025 | Q3 2025 Aug 30, 2025 | Q2 2025 May 30, 2025 | Q1 2025 Feb 27, 2025 | Q4 2024 Nov 29, 2024 | Q3 2024 Aug 30, 2024 | Q2 2024 May 30, 2024 | Q1 2024 Feb 28, 2024 | Q4 2023 Nov 29, 2023 | Q3 2023 Aug 30, 2023 | Q2 2023 May 30, 2023 | Q1 2023 Feb 27, 2023 | Q4 2022 Nov 29, 2022 | Q3 2022 Aug 30, 2022 | Q2 2022 May 30, 2022 | Q1 2022 Feb 27, 2022 | Q4 2021 Nov 29, 2021 | Q3 2021 Aug 30, 2021 | Q2 2021 May 30, 2021 | Q1 2021 Feb 27, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9.04M | 6.25M | 13.58M | 7.89M | 44.06M | 18.45M | 13.28M | 12.59M | 12.09M | 16.59M | 15.16M | 18.47M | 30.68M | 12.69M | 6.78M | 10.79M | 11.43M | 9.62M | 7.4M | 10.25M | 7.09M | 5.01M |
Cost of Revenue | n/a | 84.14M | 4.63M | 5M | 78.1M | 69.66M | 67.22M | 55.48M | 48.92M | 50.01M | 49.71M | 47.86M | 45.76M | 45.82M | 46.11M | 47.76M | 47.49M | 43.14M | 36.53M | 30.91M | 25.99M | 23M |
Gross Profit | 9.04M | -77.89M | 8.95M | 2.89M | -34.04M | -51.21M | -53.94M | -42.89M | -36.83M | -33.42M | -34.55M | -29.39M | -15.09M | -33.13M | -39.32M | -36.97M | -36.06M | -33.52M | -29.14M | -20.65M | -18.9M | -17.99M |
Operating Income | -94.2M | -92.5M | -83.1M | -91.39M | -48.32M | -62.86M | -64.66M | -54.61M | -48.54M | -45.22M | -45.33M | -40.01M | -26.77M | -42.95M | -48.69M | -46.72M | -45.72M | -42.74M | -37.95M | -29M | -26.41M | -24.52M |
Interest Income | 4.4M | 5.32M | 4.87M | 4.96M | 5.62M | 6.51M | 6.12M | 5.74M | 4.08M | 3.79M | 3.38M | 3.03M | 2.49M | 2.22M | 1.97M | 1.01M | 314K | 211K | 295K | 39K | 171K | 318K |
Pretax Income | -89.81M | -87.17M | -78.22M | -86.42M | -42.7M | -56.35M | -58.54M | -48.87M | -44.46M | -41.43M | -41.96M | -36.98M | -24.28M | -40.73M | -46.72M | -45.71M | -45.4M | -42.53M | -37.66M | -28.96M | -26.24M | -24.2M |
Net Income | -89.54M | -87.17M | -78.22M | -86.42M | -43.46M | -56.35M | -58.55M | -48.96M | -44.55M | -41.52M | -41.96M | -36.98M | -24.28M | -40.73M | -46.72M | -45.71M | -45.4M | -42.53M | -37.7M | -28.84M | -26.38M | -24.28M |
Selling & General & Admin | 15.59M | 14.61M | 13.65M | 13.16M | 14.28M | 11.65M | 10.72M | 11.72M | 11.71M | 11.8M | 10.78M | 10.62M | 11.68M | 9.82M | 9.37M | 9.75M | 9.65M | 9.23M | 8.82M | 8.34M | 7.51M | 6.53M |
Research & Development | 87.65M | 84.14M | 80.9M | 86.12M | 78.1M | 69.66M | 67.22M | 55.48M | 48.92M | 50.01M | 49.71M | 47.86M | 45.76M | 45.82M | 46.11M | 47.76M | 47.49M | 43.14M | 36.53M | 30.91M | 25.99M | 23M |
Other Expenses | n/a | -84.14M | -2.51M | -5M | -78.1M | -69.66M | -67.22M | -55.48M | -48.92M | -50.01M | -49.71M | -47.86M | -45.76M | -45.82M | -46.11M | -47.76M | -47.49M | -43.14M | -36.53M | -30.91M | -25.99M | -23M |
Operating Expenses | 103.25M | 14.61M | 92.04M | 94.28M | 14.28M | 11.65M | 10.72M | 11.72M | 11.71M | 11.8M | 10.78M | 10.62M | 11.68M | 9.82M | 9.37M | 9.75M | 9.65M | 9.23M | 8.82M | 8.34M | 7.51M | 6.53M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 103.25M | 98.75M | 96.67M | 99.28M | 92.38M | 81.32M | 77.94M | 67.2M | 60.63M | 61.8M | 60.49M | 58.48M | 57.44M | 55.64M | 55.47M | 57.51M | 57.15M | 52.37M | 45.35M | 39.25M | 33.51M | 29.53M |
Income Tax Expense | -271K | n/a | n/a | n/a | 760K | n/a | 8K | 82K | 90K | 90K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 44K | -123K | 139K | 71K |
Shares Outstanding (Basic) | 111.08M | 110.07M | 95.09M | 84.16M | 83.88M | 83.56M | 78.41M | 72.78M | 62.38M | 54.9M | 54.67M | 54.39M | 54.26M | 54.03M | 53.94M | 50.87M | 44.9M | 44.69M | 44.55M | 44.37M | 43.8M | 38.78M |
Shares Outstanding (Diluted) | 111.08M | 110.07M | 95.09M | 84.16M | 83.88M | 83.56M | 78.41M | 72.78M | 62.38M | 54.9M | 54.67M | 54.39M | 54.26M | 54.03M | 53.94M | 50.87M | 44.9M | 44.69M | 44.55M | 44.37M | 43.8M | 38.78M |
EPS (Basic) | -0.81 | -0.79 | -0.82 | -1.03 | -0.52 | -0.67 | -0.75 | -0.67 | -0.71 | -0.76 | -0.77 | -0.68 | -0.40 | -0.65 | -0.77 | -0.88 | -1 | -0.95 | -0.85 | -0.65 | -0.60 | -0.63 |
EPS (Diluted) | -0.81 | -0.79 | -0.82 | -1.03 | -0.52 | -0.67 | -0.75 | -0.67 | -0.71 | -0.76 | -0.77 | -0.68 | -0.40 | -0.65 | -0.77 | -0.88 | -1 | -0.95 | -0.85 | -0.65 | -0.60 | -0.63 |
EBITDA | -89.81M | -83.4M | -68.96M | -81.42M | -40.46M | -54M | -57.29M | -46.48M | -42.13M | -39.38M | -41.42M | -35.03M | -22.38M | -38.98M | -46.3M | -44.25M | -44.12M | -41.54M | -36.9M | -28.21M | -25.77M | -23.88M |
EBIT | -89.81M | -87.17M | -78.22M | -86.42M | -42.7M | -56.35M | -58.54M | -48.87M | -44.46M | -41.43M | -41.96M | -36.98M | -24.28M | -40.73M | -46.72M | -45.71M | -45.4M | -42.53M | -37.66M | -28.96M | -26.41M | -24.52M |
Depreciation & Amortization | n/a | 3.78M | 9.26M | 5M | 2.24M | 2.35M | 1.25M | 2.39M | 2.33M | 2.05M | 534K | 1.95M | 1.9M | 1.75M | 419K | 1.46M | 1.28M | 991K | 757K | 745K | 645K | 643K |
Add to Watchlist
Select watchlists to add or remove NRIX